172 related articles for article (PubMed ID: 9311142)
1. Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundii.
Nishino Y; Deguchi T; Yasuda M; Kawamura T; Nakano M; Kanematsu E; Ozeki S; Kawada Y
FEMS Microbiol Lett; 1997 Sep; 154(2):409-14. PubMed ID: 9311142
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
4. Sparfloxacin resistance in clinical isolates of Streptococcus pneumoniae: involvement of multiple mutations in gyrA and parC genes.
Taba H; Kusano N
Antimicrob Agents Chemother; 1998 Sep; 42(9):2193-6. PubMed ID: 9736534
[TBL] [Abstract][Full Text] [Related]
5. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
Akasaka T; Tanaka M; Yamaguchi A; Sato K
Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
[TBL] [Abstract][Full Text] [Related]
6. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
Weigel LM; Steward CD; Tenover FC
Antimicrob Agents Chemother; 1998 Oct; 42(10):2661-7. PubMed ID: 9756773
[TBL] [Abstract][Full Text] [Related]
7. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.
Tankovic J; Perichon B; Duval J; Courvalin P
Antimicrob Agents Chemother; 1996 Nov; 40(11):2505-10. PubMed ID: 8913454
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
[TBL] [Abstract][Full Text] [Related]
9. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
[TBL] [Abstract][Full Text] [Related]
10. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Ezaki T; Saito I; Kawada Y
Antimicrob Agents Chemother; 1996 Apr; 40(4):1020-3. PubMed ID: 8849219
[TBL] [Abstract][Full Text] [Related]
11. Partial characterisation of the acrAB locus in two Citrobacter freundii clinical isolates.
Sánchez-Céspedes J; Vila J
Int J Antimicrob Agents; 2007 Sep; 30(3):259-63. PubMed ID: 17631985
[TBL] [Abstract][Full Text] [Related]
12. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis.
Li Z; Deguchi T; Yasuda M; Kawamura T; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
Antimicrob Agents Chemother; 1998 Dec; 42(12):3293-5. PubMed ID: 9835531
[TBL] [Abstract][Full Text] [Related]
13. Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.
Tanaka M; Takahashi K; Saika T; Kobayashi I; Ueno T; Kumazawa J
J Urol; 1998 Jun; 159(6):2215-9. PubMed ID: 9598572
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.
Kanematsu E; Deguchi T; Yasuda M; Kawamura T; Nishino Y; Kawada Y
Antimicrob Agents Chemother; 1998 Feb; 42(2):433-5. PubMed ID: 9527801
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.
Okuda J; Hayakawa E; Nishibuchi M; Nishino T
Antimicrob Agents Chemother; 1999 May; 43(5):1156-62. PubMed ID: 10223929
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
Deguchi T; Fukuoka A; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Ban Y; Kawada Y
Antimicrob Agents Chemother; 1997 Mar; 41(3):699-701. PubMed ID: 9056017
[TBL] [Abstract][Full Text] [Related]
17. Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium.
el Amin NA; Jalal S; Wretlind B
Antimicrob Agents Chemother; 1999 Apr; 43(4):947-9. PubMed ID: 10103206
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.
González I; Georgiou M; Alcaide F; Balas D; Liñares J; de la Campa AG
Antimicrob Agents Chemother; 1998 Nov; 42(11):2792-8. PubMed ID: 9797205
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
Jalal S; Wretlind B
Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
